usobesityscience.org
@usobesityscience.org
The American Metabolic Research Institute publishes independent clinical research on GLP-1 receptor agonists, lipase inhibitors, and pharmacotherapeutic strategies for obesity and metabolic disease.
usobesityscience.org's Company Logos
No logo added yet.
usobesityscience.org's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D03939
Persian Red
208, 57, 57
0, 62, 52
0, 73, 73, 18
#393939
Mine Shaft
57, 57, 57
0, 0, 22
0, 0, 0, 78
#FFDB9D
Cream Brulee
255, 219, 157
38, 100, 81
0, 14, 38, 0
About usobesityscience.org
The American Metabolic Research Institute (AMRI) is a nonprofit organization based in Boston, dedicated to pioneering clinical research focused on metabolic health and weight management. Founded in 2009, AMRI emphasizes the evaluation of pharmacotherapeutic strategies, particularly GLP-1 receptor agonists and lipase inhibitors, aimed at combating obesity and related metabolic diseases. The institute synthesizes data from randomized controlled trials and longitudinal studies to enhance clinical practices in obesity medicine.
AMRI's exploration includes prominent drug classes such as Semaglutide, Liraglutide, Tirzepatide, and Orlistat, providing critical analyses to healthcare professionals. The organization also addresses safety concerns related to medication procurement, ensuring that patients and clinicians can navigate a complex landscape of prescription options safely. With over 180 published analyses and a dedicated research team led by experts like Dr. Sarah Jenkins, AMRI plays a vital role in shaping the future of obesity pharmacotherapy, striving for effective solutions to improve patient outcomes in metabolic health.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
